Featured News
LuGENE® Lupus Test Launches to Predict Flares & Drug Targets
AMPEL BioSolutions’ Precision Medicine Breakthrough Predicts Drug Options with RNA Analytics & Machine Learning
Virginia Workforce Award to AMPEL BioSolutions
AMPEL on Bloomberg Markets
Lupus, coronary artery disease share genetic risk factors; data may lead to early testing
Innovator-of-Year to AMPEL
COMPANY
Innovators, Educators, and Entrepreneurs Recognized at North Fork (AMPEL’s 1st Office)
2023 CBIC Awards recipients announced. On June 1, North Fork was the 2023 CBIC Awards Gala venue, where innovators, educators, and entrepreneurs came together to celebrate.
UVA Students & Alums Succeed at AMPEL
CLICK TO VIEW ALUMNI BIOS >
AMPEL BioSolutions’ Precision Medicine Breakthrough Predicts Drug Options with RNA Analytics & Machine Learning
AMPEL BioSolutions today announces a breakthrough in precision and personalized medicine that could modernize the way doctors treat patients across a wide variety of diseases including autoimmunity, infectious disease and cancer.
Potential Employers Descend on Grounds During Annual Career Fair
CLICK TO VIEW ORIGINAL ARTICLE > by Caroline Newman, news@virginia.edu On Wednesday and Thursday, University of Virginia students donned their professional best and headed to Newcomb Hall for the annual Fall Job and Internship Fair, where they met with recruiters...
Eight Innovative, Virginia Life Science Startups to Know
There are a host of exciting, innovative startup companies that call Charlottesville home. We’re excited to highlight these nine innovative Charlottesville, Virginia startup companies and look forward to telling their stories well into the future.
Central Virginia Is Experiencing a Biotech Boom
Strong talent pipeline and excellent resources help fuel the biotechnology industry in Charlottesville and the surrounding communities.
PLATFORM
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
PRODUCTS
New Lupus Test Predicts Flares & Drug Targets
From RNA gene expression in cells circulating in the blood, LuGENE identifies real-time abnormalities leading to inflammation and immune system dysfunction that are targetable by medication.
Revolutionizing Lupus Care with Advanced Predictive Blood Testing
AMPEL BioSolutions introduces LuGENE®, a cutting-edge blood test poised to revolutionize the management of systematic lupus erythematosus (SLE). LuGENE® leverages predictive artificial intelligence (AI) to detect genetic biomarkers indicative of inflammation-driven SLE flares, offering clinicians valuable insights for tailored treatment strategies.
AMPEL BioSolutions Selected as Member of Prestigious Federal Health Innovation ARPA-H Network
AMPEL BioSolutions has been selected as a member – or “spoke” – of the Customer Experience Hub of ARPANET-H, a prestigious nationwide health innovation network launched by the Advanced Research Projects Agency for Health (ARPA-H).
LuGENE Launches in LA: Podcast with Dr. Dan Wallace
This #NewsFromTheLab session welcomes the creators of the new LuGENE lab test by Ampel BioSolutions! Watch Dr. Amrie Grammer and Dr. Peter Lipsky share about the cutting-edge LuGENE® Blood Test, a revolutionary tool designed to predict flare activity and drug targets in lupus, offering new hope and possibilities for patients.
LuGENE blood test for lupus flares, drug targets enters open-label study
LuGENE, a blood test to predict lupus flares and quickly identify drug targets, is being made available to patients around the United States through an open-label study, according to a press release from the manufacturer.
New blood test predicts flares before they happen
Ampel Biosolutions announced the launch of LuGENE®, a blood test that uses artificial intelligence (AI) to look at a patient’s gene activity and predict when lupus flares are likely to happen and which medications could be most effective to keep symptoms in check.
PARTNERS
Lupus Treatment with Omega3-Rich Krill Oil Improves Disease Activity
Increasing Omega-3 Index to an optimal level through Krill Oil supplementation may show benefit for this population and warrants further study.
Lupus Treatment with Omega3-Rich Krill Oil Improves Disease Activity
Several patients experienced a sustained improvement in disease activity in parallel with improved omega-3 index.
Lupus Treatment with Omega3-Rich Krill Oil Improves Disease Activity
With the concentrated Superba Boost preparation of Krill Oil, we were able to bring omega3 levels into the range of protection from cardiovascular disease and to improve disease activity in those with more active Lupus.
Lupus Treatment with Omega3-Rich Krill Oil Improves Disease Activity
The body’s immune system normally fights off infections, but the cells of an autoimmune individual are in a constant state of inflammation that specifically targets one’s own tissues like kidneys
Lupus Treatment with Omega3-Rich Krill Oil Improves Disease Activity
Omega3 lipids called polyunsaturated fatty acids (PUFAs) that are found in microscopic shrimp-like crustaceans called Krill from the waters around Antarctica are key to maintaining a low inflammatory state.
Statement in Response to Recent Lupus Science and Medicine Publication
Research has shown that people with lupus are at an elevated risk of cardiovascular complications. Increasing Omega-3 Index to an optimal level through krill oil supplementation may show benefit for this population but warrants further study.